市場調查報告書
商品編碼
1522702
全球接骨植入物市場:按產品類型、材料、骨折類型、最終用戶和地區進行預測(~2032 年)Global Osteosynthesis Implants Market Research Report Information By Product, By Material, By Fracture Type, By End User and by Region - Forecast till 2032 |
預計骨縫合植入物市場規模將從2023年的54億美元和2024年的56.7億美元成長到2032年的96.6億美元,預測期內複合年增長率為6.11%。
推動全球接骨植入物市場成長的兩個主要因素是全球骨折率上升和骨質疏鬆症。儘管與骨合成植入物相關的一些課題預計也會限制全球市場的擴張,但正在進行的臨床試驗、技術突破和全球人口老化預計將使市場有利可圖。
骨量減少和脆性增加是骨質疏鬆症的標誌,並對骨折治療提出了重大課題。骨折在骨質疏鬆症患者中很常見,尤其是髖部、脊椎和手腕等承重骨。骨質疏鬆性骨骼中的骨折通常會帶來特殊問題,因為受損骨骼的品質會降低且其機械穩定性也會降低。骨接合植入物對於骨質疏鬆患者的骨折治療至關重要,因為它們可以提供機械支撐並促進骨折癒合。
隨著全球骨質疏鬆症盛行率的增加,對骨縫合植入物的需求也增加。根據International Osteoporosis Foundation預測,2019年全球可能有5億男性和女性受到骨質疏鬆的影響,每三秒就有一人因骨質疏鬆而骨折。
區域視角
預計2022年北美地區佔比將達39.76%,複合年增長率為6.33%,2032年達39.8億美元。同時,歐洲預計在預測期內將以 7.35% 的最高複合年增長率成長。
北美接骨植入物市場預計將穩定發展,前景依然樂觀。該市場的驅動因素包括創傷和運動傷害的高發生率、骨科手術數量的增加以及一流的醫療基礎設施和服務。
由於多種因素,包括運動傷害的增加、骨質疏鬆症盛行率的增加以及患者對手術幹預益處的認識不斷提高,歐洲市場目前正在迅速擴張。
亞太地區預計在預測期內複合年增長率為 5.13%,2022 年為 9.9 億美元。世界其他地區預計將從 2022 年的 7.1 億美元開始成長,在預測期內複合年增長率為 2.76%。
本報告調查了全球骨縫合植入物市場,並提供了市場定義和概述、市場成長影響因素和市場機會分析、市場規模趨勢和預測,以及按不同細分市場、地區和主要國家進行的細分、競爭環境及概況。
Global Osteosynthesis Implants Market Research Report Information By Product (Screws and Plates, Wires and Pins, Intramedullary Rods and Nails, and Spinal Fixation Devices), By Material (Stainless Steel, Titanium and Titanium Alloys, Bioabsorbable Polymers, and Others), By Fracture Type (Hip Fracture, Knee Fracture, Spine Fracture, Shoulder Fracture, and Others), By End User (Hospitals, Orthopaedic Clinics, and Ambulatory Surgical Centers) and by Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2032
The market for osteosynthesis implants was estimated to be worth USD 5.40 billion in 2023. According to projections, the market for osteosynthesis implants would increase at a compound annual growth rate (CAGR) of 6.11% from USD 5.67 billion in 2024 to USD 9.66 billion by 2032.
The two main drivers propelling the growth of the global osteosynthesis implant market are rising rates of fractures and osteoporosis worldwide. Nonetheless, it is anticipated that the difficulties related to osteosynthesis implants will limit the worldwide market's expansion. However, the market is expected to see profitable prospects due to ongoing clinical trials, increased technology breakthroughs, and an aging population globally.
Decreased bone mass and increased brittleness are the hallmarks of osteoporosis, which presents major problems for fracture care. Fractures are more common in people with osteoporosis, especially in weight-bearing bones like the hip, spine, and wrist. Because the quality of the damaged bone is lower and the mechanical stability is decreased, fractures in osteoporotic bones frequently pose special issues. Because they produce mechanical support and promote fracture healing, osteosynthesis implants are an essential part of the treatment of fractures in patients with osteoporosis.
The need for osteosynthesis implants is rising due to the rising prevalence of osteoporosis worldwide. For example, the International Osteoporosis Foundation stated in 2019 that 500 million men and women worldwide may be impacted by osteoporosis, and that a person breaks a bone owing to the condition every three seconds.
Insights on Market Segments
Based on products, screws and plates, wires and pins, intramedullary rods and nails, and spinal fixation devices, the worldwide osteosynthesis implants are segmented.
Based on material, the osteosynthesis implants market is segmented into categories such as bioabsorbable polymers, titanium and titanium alloys, stainless steel, and others.
Based on the kind of fracture, the osteosynthesis implants market has been divided into segments: hip, knee, spine, shoulder, and others.
Based on the end user, the osteosynthesis implants market has been divided into ambulatory surgical centers, orthopedic clinics, and hospitals.
Area Perspectives
The market is divided into four regions by the study: North America, Europe, Asia-Pacific, and the Rest of the World. Osteosynthesis implants in North America held the most market share of 39.76% in 2022 and are expected to grow at a compound annual growth rate (CAGR) of 6.33% to reach a projected USD 3.98 billion by 2032. Nonetheless, throughout the course of the projection period, Europe is expected to develop at the highest CAGR of 7.35%.
The market for osteosynthesis implants in North America is expected to develop steadily, and the outlook is still positive. The osteosynthesis implants market is driven by factors such as a high rate of trauma and sports injuries, an increase in orthopedic procedures, and first-rate healthcare infrastructure and services.
The market for osteosynthesis implants in Europe is currently experiencing rapid expansion due to a number of factors, including an increase in sports injuries, an increase in the prevalence of osteoporosis, and a growing patient awareness of the advantages of surgical intervention.
Osteosynthesis implants in Asia-Pacific were valued at USD 0.99 billion in 2022, and during the forecast period, the market is expected to increase at a compound annual growth rate (CAGR) of 5.13%. The Osteosynthesis Implants market for the Rest of the World was valued at USD 0.71 billion in 2022 and is anticipated to expand at a compound annual growth rate (CAGR) of 2.76% over the forecast period.
Principal Players
Medartis AG, Dieter Marquardt Medizintechnik GmbH, Lepu Medical Technology (Beijing)Co.,Ltd., Globus Medical, Inc., Zimmer Biomet, Arthrex, Inc., Precision Spine, Inc., Johnson & Johnson Services, Inc., CONMED Corporation, and Braun SE are some of the major companies in the osteosynthesis implant market.